Press Releases OssDsign AB

Equities

Delayed Nasdaq Stockholm Other stock markets 05:23:09 2024-05-15 EDT			5-day change	1st Jan Change
9.16 ^SEK	-4.98%		-9.31%	+14.50%

05-14	Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024
05-14	OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

OssDsign Q1 - An accelerating turnaround	02:16am	AQ
OssDsign: A new beginning – Q1 review	12:24am	AQ
OssDsign AB (publ) publishes Q1 2024 interim report	05-14	AQ
OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals	04-29	AQ
OssDsign: Another quarter of triple-digit Catalyst growth expected	04-11	AQ
OssDsign awarded long-term agreement with Premier, Inc.	04-02	AQ
OssDsign: Update after HC seminar and news in the spinal fusion market	03-07	AQ
OssDsign appoints Tom Buckland as Chief Technical Officer	02-29	AQ
OssDsign: Restructuring completed, focus on 2024	02-07	AQ
OssDsign AB (publ) publishes year-end report 2023	02-06	AQ
OssDsign: Right time to fuse the spine	01-29	AQ
12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research	01-24	AQ
OssDsign reports exceptional data from the clinical study TOP FUSION	01-09	AQ
OssDsign - Higher-than-expected Q4 preliminary sales	12-07	AQ
OssDsign's revenues for the fourth quarter of 2023 are expected to exceed market estimates	12-06	AQ
SEB Venture Capital has sold its holding in OssDsign	11-30	AQ
OssDsign changes Certified Adviser to Carnegie Investment Bank AB (publ)	11-30	AQ
OssDsign Q3 - Catalyst is growing as expected	11-22	AQ
OssDsign AB (publ) publishes Q3 2023 Interim Report	11-21	AQ
Extraordinary General Meeting held in OssDsign AB	23-10-16	AQ

No results for this search